nhs healthcare contracts

East Riding of Yorkshire Council (ERYC) is committed to achieving the best possible outcomes for all children, young people and families. This specification expresses the vision and strategic priorities to drive forward better outcomes for children, young people and families across the East Riding of Yorkshire (ERY) and aims to create and support an approach to meeting the needs of children, young people and families in the ERY. The Integrated Specialist Public Health Nursing Service (ISPHNS) will deliver the ERYC commissioned public health nursing services for children and young people aged minus 9 months to 19 (25) years (this includes the Public Health elements of the Healthy Child Programme (HCP) ) All ISPHNS will have universal service provision at their core, universal and targeted public health services are crucial to improving the health and well-being of all children, young people and their families. The universal reach of the ISPHNS provides invaluable opportunity from early in a child's life to identify families that are in need of additional support and children at risk of poor outcomes. The ERYC ISPHNS will be led by Specialist Community Public Health Nurses (SCPHN) and the elements will be delivered by a workforce consisting of appropriately trained and qualified staff. SCPHN are registered nurses or midwives with specialist additional training and registrations. The ISPHNS will provide integrated expert information, assessment and interventions for babies, children, young people and families. They will help enable them to make informed decisions that affect their health and wellbeing and will play a core role in improving the health outcomes of the East Riding eligible population and reducing health inequalities. Provider(s) will deliver and support an integrated approach to meeting the needs of C&YP, their families and the delivery of improved outcomes. Provider(s) of the ISPHNS will work in partnership with a variety of organisations; including but not limited to maternity services, local authority-provided or commissioned services, third sector, health, education, private, independent services, primary and secondary care services. Provider(s) of the ISPHNS will work with all appropriate agencies and stakeholders to achieve positive outcomes for Service Users, recognising that families may need support across the whole spectrum of services, including social care, education, health, police, voluntary organisations, safeguarding and others. Provider(s) will proactively demonstrate integrated working throughout the delivery of the ISPHNS to improve the wellbeing and life chances of every Service User.

NHS South West London Integrated Care Board (the Authority) is seeking to commission a Mental Health Support Team (MHST) service comprising 25 operational and developing MHSTs across the six boroughs. The service will provide prevention and early intervention mental health support through a standardised and equitable MHST offer, in accordance with the specified requirements, to improve access to care, reduce health inequalities, and deliver improved outcomes for children and young people across South West London. Procured through a competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023, the Authority intends to appoint a Lead Provider with overall accountability for the governance, management, and delivery of the service. The Lead Provider will oversee all operational and developing MHSTs across South West London and will be responsible for the mobilisation, delivery and service integration of future MHST teams required as part of the planned expansion to achieve 100% MHST coverage across South West London by December 2029. The decisions applicable to this Procurement will be made by the Authority. The Procurement is being managed by NHS London Commercial Hub (NHS LCH) hosted by NHS North East London, on behalf of the Authority, in connection with an Invitation to Tender (ITT) exercise that is being conducted, based on the competitive process under the Health Care Services (Provider Selection Regime) regulations 2023 ("the Regulations"(as amended). None of the references to "ITT", "Bid", or the use of the term "tender process", or any other indication, shall be taken to mean that the Authority intends to hold itself bound to any of the Regulations, save those applicable to PSR provisions regarding the Competitive Process. Further information regarding the Authority is available from: https://www.southwestlondon.icb.nhs.uk/ The lifetime Value of the contract is £89,916,960 excluding VAT. The contract term is for three (3) years with an option for extension of further three (1 + 1 + 1) years at the sole discretion of the Authority. The contract will start on 01/04/2027 and end 31/03/2030, if the 1 + 1 + 1 optional extensions are utilised the maximum contract end date will be 31/03/2033. The maximum duration of the contract is 6 years (72 months). Further details of the procurement, including service requirements are included in the procurement documents.

Dioptre Consumables

The Trust invites quotations for the supply and delivery of 11 new mobile patient hoists for use in an inpatient setting. The hoists must support transfers between beds, chairs and wheelchairs, have a base suitable for use beneath low beds, and have a minimum safe working load of 130 kg. With a powered lifting system Delivery will be to Orsett Hospital, Rowley Road, Grays, RM16 3EU. Quotations must include all delivery charges to this location.

The development of an automated digital musculoskeletal (MSK) Single Point of Access (SPA) tool for BHFT's community physiotherapy (MSK Physio), specialist physiotherapy (Community Specialist Service – CSS), integrated pain and spinal service (IPASS) and MSK podiatry.

The primary objective of the Service is to provide a proactive, responsive, and effective pest management programme that minimises pest-related risks, supports infection prevention and control objectives, protects the Trust’s assets and reputation, and maintains a safe and welcoming environment for patients, staff, visitors and Suppliers.

Lincolnshire Partnership Foundation Trust requires a Service Provider to undertake the administration and management of the Mental Health and Wellbeing Community Investment Fund (MHWCIF). The provider will administer grant application and award processes, undertake due diligence and governance activities, manage and monitor funding allocated to VCFSE organisations, provide financial and performance reporting, support funded organisations with capacity building and volunteer development, and evaluate and report on outcomes achieved through community-based mental health and wellbeing projects across Lincolnshire.

Betsi Cadwaladr University Health Board requires a suitably qualified and experienced contractor to undertake the refurbishment and reconfiguration of the existing Dental Decontamination Room at Mold Community Hospital, Ash Grove, Mold, to support the delivery of compliant dental decontamination services. The project forms part of the Health Board's ongoing programme of estate improvements and will provide upgraded facilities that meet current healthcare standards and operational requirements. The full details are outlined with the tender documents attached within Bravo. The tender will be awarded to the most advantageous tender based on 40% quality and 60% cost as detailed in the ITT document. Please note that the tender closing date is 2/11/2026 at midday and any late submissions will not be considered. The etenderwales bravosolution ref: https://etenderwales.bravosolution.co.uk Project: project_64155 and itt_127702 Please direct all queries relating to this tender via the messaging function of the Bravo portal.

The contract is expected to initially be delivered for NHS-funded care in England and Wales, and publicly funded care in Jersey for a period of three years, at a maximum total budget of up to £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other Devolved Nations and/or Crown Dependencies, aspirational measures and discretionary inflationary uplifts (all of which will be defined in the service specification). The maximum budget ‘core’ value of £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT, excludes the potential two-year extension and aspirational intent as included in section 14.4 of Annex A - Service Specification The contract may be extended for up to 24 months at a pro rata value of the core three- year funding, estimated at up to £518,877 excluding VAT. This proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first three years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year three, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year. Further to this funding, the specification contains a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, including the potential two- year extension and core 3 year value means an overall ceiling value for this contract of up to £6,417,788 excluding VAT and £7,701,346 including VAT. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures listed in section 14.4 of Annex A - Service Specification The role of a national clinical audit is to stimulate healthcare quality improvement through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against available national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals who are engaging with and using the audit results are also in a position to improve the system, and where there is a shared understanding of what good care looks like. National clinical audits are expected to: a.Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national healthcare quality improvement. b.Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience. c.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate. d.Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting. e.Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit. f.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future and plan for these linkages from the inception of the contract. g.Ensure robust methodological and statistical input at all stages of the audit. h.Identify from the outset the full range of audiences for the reports and other audit outputs and plan and tailor them accordingly. i.Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data. j.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget. k.Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services. l.Deliver high-quality audit outputs, benchmarking and quality improvement as a priority. At the time of writing the specification, requirements include (but please also refer to the potential future aspirational intent section): 1. Audit Purpose The overall ambition of the audit is to continue to capture and report data on the performance of individual healthcare providers against the National Institute for Health and Care Excellence (NICE) Quality Standard QS33: Rheumatoid Arthritis in Adults, Quality standard QS214: Rare diseases, and other relevant national standards and guidance, (see Appendix 1). 2. Paediatric Inflammatory Arthritis Pathway The supplier should work with the wider Dataset and Methodology Stakeholder Group to develop, maintain and report against a minimum viable paediatric inflammatory arthritis pathway. The initial focus should be on establishing a clinically meaningful dataset and reporting framework sufficient to describe the patient pathway and support audit activity. Initial measures should focus on a limited number of priority areas agreed with funders and stakeholders, for example referral, diagnosis and treatment timelines. The updated GIRFT Paediatric Inflammatory Arthritis Pathway guidance, anticipated for publication in January 2027, should be considered a key reference for the future development of the dataset, measures and reporting framework. The supplier should work with the wider Dataset and Methodology Stakeholder Group to review and align the dataset, metrics and reporting outputs with the recommendations and standards set out within the GIRFT guidance, ensuring ongoing relevance and consistency with national best practice. Any expansion beyond the core pathway, including additional metrics, PROMs/PREMs, transition measures and broader pathway development, should be considered future aspirational intent subject to feasibility, resources and further funding. 3. Data Collection and Audit Design The supplier should continue to deliver a continuous prospective clinical audit and work with the Dataset and Methodology Group to ensure the audit dataset remains clinically relevant and proportionate. The supplier is expected to collaborate with specialist disease-specific clinical groups to support interpretation of findings and improve case ascertainment and recruitment rates. 4. Organisational Survey and Quality Improvement The supplier should review and maintain the organisational survey to ensure it remains proportionate and aligned with audit objectives. Priority should be given to maximising analysis and utilisation of existing data rather than increasing data collection burden in collaboration with the wider Dataset and Methodology Stakeholder Group. The organisational survey should support the audit's quality improvement objectives by enabling a deeper understanding of service delivery, workforce capacity, variation in practice and barriers to high-quality care. 5. Benchmarking and Improvement The audit is expected to support continuous improvement across all services. While identifying high-performing and outlier services remains important, the audit should also support improvement among services performing at or around the national average, where the greatest overall gains may be achieved. Benchmarking should encourage year-on-year improvement within individual services and provide meaningful insights that motivate all providers to improve, regardless of their current position relative to national performance. 6. Targeted improvement support The supplier should provide targeted quality improvement support following each annual audit cycle. Activities should build on existing professional networks, collaboratives and stakeholder infrastructure wherever possible rather than creating wholly new arrangements. Improvement support should be designed to benefit healthcare providers across the performance spectrum, including those performing at a middle level where the greatest overall gains may be achieved, while also supporting services experiencing significant challenges or demonstrating exceptional practice. Learning generated through quality improvement activities should be shared with all participating healthcare providers to maximise the impact of the audit programme. The anticipated outputs are: 1.Near real-time dynamic and interactive metric results. 2.Publication of an annual state of the nation report with the inclusion of an organisational survey. 3.Incorporation of validated Patient Reported Outcome Measures. 4.Quality improvement resources. 5.The identification and notification of outliers. For further information on the current audit, currently delivered by the British Society for Rheumatology (BSR) please head to: https://www.rheumatology.org.uk/improving-care/audits/neiaa

NHS Fife is seeking to procure the supply, installation, commissioning, maintenance and ongoing support of a fully inclusive liquid chemical dosing system lease, together with all required detergents and associated chemicals.

Public Health Wales are looking for a highly qualified and experienced contractor to deliver comprehensive maintenance and repair services for Public Health Wales Infection Services. This includes the inspection, maintenance, repair and calibration of all pipettes used within PHW Infection Services. Public Health Wales Trust recognises the importance of the Welsh Language to the communities it serves. Consequently, responses to an invitation to quote or tender will be accepted in Welsh as well as English. However, please note that tender responses submitted only in Welsh will be translated by the Health Board into English before consideration. Those involved in translating the document will be barred from taking decisions on awarding tenders. Full details outlining the scope of the works are contained within the eTender Wales invitation to Tender. The tender will be awarded to the most economically advantageous tender based on 40% quality and 60% cost as detailed in the ITT document. Please note that the tender closing date is 02/11/2026 at midday and any late submissions will not be considered. The etenderwales bravosolutions ref:project_64080 and itt_127653. Please direct all queries relating to this tender via the messaging function of the Bravo portal. More details can be found at https://etenderwales.ukp.app.jaggaer.com/esop/toolkit/dashboard/dashboard.do?_ncp=1790771139229.944241-1

Vending Beverage and Snack Products and Services

This opportunity is being run under the Provider Selection Regime (PSR) regulations. The development of a specialist all age mental health response via 111 is a key ambition of the NHS England Long Term Plan (2021-2024), and the recovery plan for urgent and emergency care priority for 2023/24. This required all calls for support during mental health crisis to be made via 111 by the end of March 2024 and is referred to as 111-2. Avon and Wiltshire Mental Health Partnership NHS Trust (AWP) currently deliver this service in partnership with a system partner. AWP is seeking a provider to deliver an integrated model for the NHS 111 Mental Health Crisis Response Service (111 Option 2) for individuals experiencing a mental health crisis across both adult (18 years and over) and children and young people (under 18 years) pathways. The appointed provider will be solely responsible for the delivery of the call handling element of the 111 Option 2 pathway, including access, triage and call management. AWP will retain responsibility for all clinical assessment activity and associated clinical decision-making and outcomes. The provider must be able to operate within a matrix management model, whereby all partners maintain responsibility for their own governance arrangements, professional standards and areas of specialist expertise, while working collaboratively at both strategic and operational leadership levels to deliver a seamless, integrated and high-quality service. The service forms part of the NHS England requirement that callers contacting NHS 111 and selecting the mental health option are connected directly to a dedicated mental health response service available 24 hours per day, 7 days per week. The service will work collaboratively with urgent and emergency care pathways, crisis services, community mental health teams, acute hospitals, ambulance services, primary care and voluntary sector partners. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18282. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18282 as the reason for registration.

This opportunity is being run under the Provider Selection Regime (PSR) regulations. The development of a specialist all age mental health response via 111 is a key ambition of the NHS England Long Term Plan (2021-2024), and the recovery plan for urgent and emergency care priority for 2023/24. This required all calls for support during mental health crisis to be made via 111 by the end of March 2024 and is referred to as 111-2. Avon and Wiltshire Mental Health Partnership NHS Trust (AWP) currently deliver this service in partnership with a system partner. AWP is seeking a provider to deliver an integrated model for the NHS 111 Mental Health Crisis Response Service (111 Option 2) for individuals experiencing a mental health crisis across both adult (18 years and over) and children and young people (under 18 years) pathways. The appointed provider will be solely responsible for the delivery of the call handling element of the 111 Option 2 pathway, including access, triage and call management. AWP will retain responsibility for all clinical assessment activity and associated clinical decision-making and outcomes. The provider must be able to operate within a matrix management model, whereby all partners maintain responsibility for their own governance arrangements, professional standards and areas of specialist expertise, while working collaboratively at both strategic and operational leadership levels to deliver a seamless, integrated and high-quality service. The service forms part of the NHS England requirement that callers contacting NHS 111 and selecting the mental health option are connected directly to a dedicated mental health response service available 24 hours per day, 7 days per week. The service will work collaboratively with urgent and emergency care pathways, crisis services, community mental health teams, acute hospitals, ambulance services, primary care and voluntary sector partners. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18282. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18282 as the reason for registration. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18282. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18282 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Gloucestershire Health and Care NHS Foundation Trust ("the Authority") is seeking to appoint a suitably qualified and experienced provider for the delivery of Physical Pharmacy Services across its Physical Health services within Gloucestershire. The Authority delivers a diverse range of community-based, outpatient, rehabilitation, intermediate care, and inpatient physical healthcare services. The successful contractor will be required to provide a comprehensive, safe, effective, and patient-centred pharmacy service that supports the delivery of high-quality clinical care, medicines optimisation, and statutory compliance across the Trust's physical health portfolio. The service will be expected to provide expert pharmacy support, including but not limited to medicines management, medicines optimisation, clinical pharmacy input, governance and assurance activities, medicines reconciliation, prescribing support, staff training and education, audit and quality improvement activities, and specialist pharmaceutical advice to multidisciplinary teams. The Authority is seeking a provider that can demonstrate: Extensive experience in delivering pharmacy services within NHS and/or comparable healthcare environments; Strong clinical governance and medicines safety arrangements; - A skilled and resilient workforce capable of supporting services across multiple care settings; - The ability to work collaboratively with clinical teams and system partners; - Innovative approaches to medicines optimisation and service improvement; - Robust digital capabilities, reporting arrangements, and data management processes; and - A commitment to delivering high-quality patient outcomes, value for money, sustainability, and social value. The contract will support the Authority's strategic objectives by ensuring that patients receive safe, effective, and timely pharmaceutical care, while promoting the appropriate use of medicines and supporting service efficiency across physical healthcare pathways. The procurement will be conducted through an open and transparent competitive process. Tender submissions will be evaluated on the basis of the Most Advantageous Tender (MAT), taking into account quality, service delivery, clinical governance, social value, and commercial considerations. Full details of the evaluation methodology and award criteria will be provided within the procurement documentation. The successful provider will be expected to mobilise and maintain a service model that is responsive to changing patient needs, workforce challenges, regulatory requirements, and developments in pharmacy practice throughout the contract term. Further information relating to the scope of services, contract requirements, performance standards, Key Performance Indicators (KPIs), and contractual arrangements will be included within the Invitation to Tender documentation. Registration and documentation will be available for suppliers on Monday 21st September 2026.

Non-exclusive framework agreement for the supply of Medical Pulp Associated Products via the Stock, eDirect and Direct route to market. This includes but is not limited to; a range of products that are used to assist with the toileting of patients, collection of samples and aid the administration of procedures. The ranges of products available under the framework agreement include; Disposable Medical Pulp, Medical Pulp support products, Macerators, Bedpan Washers and Absorbent products for use with Medical Pulp. This framework agreement is for a total of 48 months. Precise quantities are unknown, however, it is anticipated that expenditure will be in the region of £120,000,000 ex VAT / £144,000,000 inc VAT throughout the duration of this framework agreement. This is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement.

The Local Government Association (LGA) is seeking a supplier to undertake a focused policy research project exploring the interaction between NHS Continuing Healthcare (CHC) and local authority adult social care. Recent evidence has highlighted growing concerns about the relationship between CHC decision-making, adult social care expenditure and the incentives created by current funding arrangements. ADASS's Spring Survey 2026 found that 75% of Directors of Adult Social Services reported an increase in the number of people presenting to adult social care who were, or previously would have been, eligible for CHC, while 84% reported that Integrated Care Board (ICB) disinvestment in CHC was contributing to adult social care overspending pressures. Research published by The King's Fund found that CHC eligibility rates have fallen significantly despite no change to the national eligibility framework, alongside substantial variation between different ICB areas. While CHC provides the primary lens for this project, the LGA is also interested in the wider question of whether current funding and accountability arrangements across health and social care create incentives that transfer costs and risks between organisations rather than supporting whole-system decision making. The LGA wishes to better understand: • How these issues are playing out locally • Whether current arrangements create misaligned incentives between organisations • The impact on local government, the NHS, people drawing on care and support, and unpaid carers • What reforms could improve alignment between health and social care funding and accountability. This work will inform future LGA policy development and engagement with government, national partners and stakeholders.

Procurement of quality assurance and improvement of GP Specialty Training structured learning placement modules to support trainee capacity and curriculum delivery.

Suffolk County Council (Public Health, Communities and Public Safety) are currently out to tender for the postal supply of Nicotine Replacement Therapy (NRT) and smoking cessation prescription medication. Smoking prevalence in Suffolk is currently estimated at 10.5%. The Council's ambition is to reduce this to 5% or below by 2030. NRT and prescribed smoking cessation medications are recognised as effective interventions to support people to quit smoking and remain an important element of the local stop smoking offer. The Council currently provides access to these products through a pharmacy-based pathway. However, not all clients are able to access participating pharmacies due to factors such as working hours, limited transport options or mobility issues. The Council is therefore exploring alternative delivery models to improve accessibility. The procurement is split into two lots. Suppliers may bid for either lot individually or for both lots. Lot 1 - Nicotine Replacement Therapy (NRT) Supply a range of NRT products following referral from the Council's commissioned stop smoking service (FGS) and deliver products directly to clients using a reliable and secure postal service. Lot 2 - Smoking cessation prescription medication Undertake remote clinical consultations with clients referred by the stop smoking service to assess suitability for Varenicline or Cytisine and, where clinically appropriate, supply medication directly to clients using a reliable and secure postal service. This opportunity is available in the 'Current Tenders' area of the portal. Interested parties are invited to express their interest to gain full access to the tender documentation. The contract period is two years with an option to extend for up to a further two years. The anticipated contract value (including the extension period) is approximately £400,000 (approximately £100,000 per annum) excluding VAT. The deadline date for submissions of the tender is 3rd November 2026 at 11am. Please note late returns will NOT be permitted. The deadline for clarification questions is 20th October 2026 which must be generated via the correspondence option on the website.

The provision of mediation training, accrediation and supervision, along with external mediation services